Gentaro Tajima

发表

Impact of expedited programs in the United States, as foreign regulatory factors, on clinical development time in Japan

N. Matsumaru, K. Tsukamoto, Gentaro Tajima, 2022, Journal of clinical pharmacy and therapeutics.

Impact of genetically modified organism requirements on gene therapy development in the EU, Japan, and the US

K. Wonnacott, Seoan Huh, Tobias T. Fleischmann, 2022, Molecular therapy. Methods & clinical development.

Impact of genetically modiﬁed organism requirements on gene therapy development in the EU, Japan, and the US

K. Wonnacott, Seoan Huh, Tobias T. Fleischmann, 2022 .